Romain‐David Seban

1.4k total citations
40 papers, 850 citations indexed

About

Romain‐David Seban is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Romain‐David Seban has authored 40 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 17 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Romain‐David Seban's work include Cancer Immunotherapy and Biomarkers (20 papers), Medical Imaging Techniques and Applications (14 papers) and Radiomics and Machine Learning in Medical Imaging (12 papers). Romain‐David Seban is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Medical Imaging Techniques and Applications (14 papers) and Radiomics and Machine Learning in Medical Imaging (12 papers). Romain‐David Seban collaborates with scholars based in France, United States and Italy. Romain‐David Seban's co-authors include Laurent Dercle, Samy Ammari, Aurélien Marabelle, Laurence Champion, François‐Clément Bidard, Éric Deutsch, Irène Buvat, Randy Yeh, Caroline Robert and Fatima‐Zohra Mokrane and has published in prestigious journals such as Radiology, European Journal of Cancer and Medical Physics.

In The Last Decade

Romain‐David Seban

36 papers receiving 845 citations

Peers

Romain‐David Seban
Bernies van der Hiel Netherlands
Hui Wu China
Somali Gavane United States
Pierpaolo Pastina Italy
Malte Kircher Germany
Sebastian E. Serfling Germany
Sabrina Rossi Italy
Thomas Guiot Belgium
Noriyuki Yamada Japan
Liza Lindenberg United States
Bernies van der Hiel Netherlands
Romain‐David Seban
Citations per year, relative to Romain‐David Seban Romain‐David Seban (= 1×) peers Bernies van der Hiel

Countries citing papers authored by Romain‐David Seban

Since Specialization
Citations

This map shows the geographic impact of Romain‐David Seban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romain‐David Seban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romain‐David Seban more than expected).

Fields of papers citing papers by Romain‐David Seban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romain‐David Seban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romain‐David Seban. The network helps show where Romain‐David Seban may publish in the future.

Co-authorship network of co-authors of Romain‐David Seban

This figure shows the co-authorship network connecting the top 25 collaborators of Romain‐David Seban. A scholar is included among the top collaborators of Romain‐David Seban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romain‐David Seban. Romain‐David Seban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nioche, Christophe, Romain‐David Seban, Nina Jehanno, et al.. (2025). Comparison of organ volumes and standardized uptake values in [18F]FDG‐PET/CT images using MOOSE and TotalSegmentator to segment CT images. Medical Physics. 52(10). e70025–e70025.
2.
3.
Seban, Romain‐David, Lounes Djerroudi, Anne Vincent‐Salomon, et al.. (2025). Are [18F]FDG PET/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?. Annals of Nuclear Medicine. 39(12). 1347–1358.
4.
Seban, Romain‐David, Laurence Champion, Florence Lerebours, et al.. (2024). Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody–drug conjugates efficacy in metastatic breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 708–718. 2 indexed citations
5.
Seban, Romain‐David, et al.. (2023). Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer. Journal of Clinical Medicine. 12(17). 5487–5487. 3 indexed citations
6.
Huang, Alice, Randy Yeh, David Khalil, et al.. (2023). PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer. Journal of Clinical Medicine. 12(15). 4882–4882. 11 indexed citations
7.
Seban, Romain‐David, Kader Chouahnia, Jean‐Baptiste Assié, et al.. (2023). Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy. Cancers. 15(8). 2223–2223. 2 indexed citations
8.
Lopci, Egesta, Romain‐David Seban, Samy Ammari, et al.. (2023). Integrating [18F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors. Cancers. 15(21). 5179–5179. 1 indexed citations
9.
Peltier, Agathe, Romain‐David Seban, Irène Buvat, François‐Clément Bidard, & Fatima Mechta‐Grigoriou. (2022). Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging. Seminars in Cancer Biology. 86(Pt 3). 262–272. 64 indexed citations
10.
Lopci, Egesta, Nicolas Aide, Antonia Dimitrakopoulou‐Strauss, et al.. (2022). Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors. Cancer Imaging. 22(1). 73–73. 10 indexed citations
11.
Seban, Romain‐David, et al.. (2021). Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT. Diagnostics. 11(5). 747–747. 5 indexed citations
12.
Toscano, F, Davide Golinelli, Helena Vila-Reyes, et al.. (2021). The Role of Cost-Effectiveness Analysis in Patient-Centered Cancer Care in the Era of Precision Medicine. Cancers. 13(17). 4272–4272. 2 indexed citations
13.
Seban, Romain‐David, Jean‐Baptiste Assié, Etienne Giroux‐Leprieur, et al.. (2021). Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy. Lung Cancer. 159. 45–55. 34 indexed citations
14.
Seban, Romain‐David, Roman Rouzier, Aurélien Latouche, et al.. (2021). Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3560–3570. 22 indexed citations
15.
Seban, Romain‐David, Antoine Moya‐Plana, Randy Yeh, et al.. (2020). Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4. European Journal of Nuclear Medicine and Molecular Imaging. 47(10). 2301–2312. 48 indexed citations
16.
Rozenblum, Laura, Fatima‐Zohra Mokrane, Randy Yeh, et al.. (2019). Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach. European Journal of Radiology. 122. 108743–108743. 8 indexed citations
17.
Dercle, Laurent, Samy Ammari, Romain‐David Seban, et al.. (2018). Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma. European Journal of Cancer. 91. 136–144. 27 indexed citations
18.
Dercle, Laurent, Romain‐David Seban, Julien Lazarovici, et al.. (2017). 18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti–Programmed Death 1 Immune Checkpoint Inhibitor. Journal of Nuclear Medicine. 59(1). 15–24. 89 indexed citations
19.
Seban, Romain‐David, et al.. (2017). The Use of FDG PET-CT Imaging for the Assessment of Early Antifungal Treatment Response in Disseminated Fusariosis. Clinical Nuclear Medicine. 42(7). 569–570. 5 indexed citations
20.
Dercle, Laurent, Laura Rozenblum, Fatima‐Zohra Mokrane, et al.. (2017). Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies. European Radiology. 28(4). 1761–1770. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernies van der Hiel Breakdown of academic impact, for papers by Hui Wu Breakdown of academic impact, for papers by Somali Gavane Breakdown of academic impact, for papers by Pierpaolo Pastina Breakdown of academic impact, for papers by Malte Kircher Breakdown of academic impact, for papers by Sebastian E. Serfling Breakdown of academic impact, for papers by Sabrina Rossi Breakdown of academic impact, for papers by Thomas Guiot Breakdown of academic impact, for papers by Noriyuki Yamada Breakdown of academic impact, for papers by Liza Lindenberg
Rankless by CCL
2026